All Stories

  1. Real-World Outcomes of SGLT2 Inhibitors in Kidney Transplant Recipients with Post-Transplant Diabetes Mellitus: An Effectiveness and Safety Analysis
  2. Agonistas do Receptor de Peptídeo Semelhante ao Glucagon-1 em Transplantados Renais - Estudo Retrospectivo de um Centro Hospitalar
  3. Glucagon-like Peptide-1 Receptor Agonists in Kidney Transplant Recipients – A Retrospective Single Center Study
  4. Comunicação na Prática Clínica, a Perspetiva dos Doentes com Cancro: Tradução do Questionário PACE (Patient Assessment Of Cancer Communication Experiences) para Português
  5. Adenovirus infection—A rare cause of interstitial nephritis in kidney transplant
  6. The association between 25(OH)D levels, frailty status and obesity indices in older adults
  7. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
  8. Psychopathological dimensions in subjects with hereditary ATTR V30M amyloidosis and their relation with life events due to the disease
  9. Life paths of patients with transthyretin-related familial amyloid polyneuropathy Val30Met: a descriptive study
  10. ESPEN diagnostic criteria for malnutrition – A validation study in hospitalized patients
  11. Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?
  12. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study
  13. End-stage renal disease versus death in a Portuguese cohort of elderly patients: an approach using competing event analysis
  14. Comparison of Jamar and Bodygrip Dynamometers for Handgrip Strength Measurement
  15. Triceps skinfold compressibility in hospitalized patients
  16. Incorporating Scoring Risk Models for Care Planning of the Elderly with Chronic Kidney Disease
  17. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation
  18. Effects of Posture and Body Mass Index on Body Girth Assessment
  19. Financial impact of sarcopenia on hospitalization costs
  20. Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments
  21. Sarcopenia and length of hospital stay
  22. Sarcopenia among hospitalized patients – A cross-sectional study
  23. A triple-biomarker approach for the detection of delayed graft function after kidney transplantation using serum creatinine, cystatin C, and malondialdehyde
  24. Impact ofde novodonor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantation
  25. Usefulness of Six Diagnostic and Screening Measures for Undernutrition in Predicting Length of Hospital Stay: A Comparative Analysis
  26. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation
  27. The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis
  28. Leptin and Adiponectin During the First Week After Kidney Transplantation: Biomarkers of Graft Dysfunction?
  29. Health-related quality of life may improve after transplantation in pancreas-kidney recipients
  30. Familial Amyloid Polyneuropathy treatment with Tafamidis – evaluation of one- and two-year treatment in Porto, Portugal
  31. Comparative analysis of undernutrition screening and diagnostic tools as predictors of hospitalisation costs
  32. Handgrip strength measurement as a predictor of hospitalization costs
  33. Adipokines in Peritoneal Dialysis: Relevant Clinical Impact According to Body Composition
  34. Handgrip strength cutoff values for undernutrition screening at hospital admission
  35. Oxidative Stress in Kidney Transplantation
  36. Pancreatic autoantibodies after pancreas-kidney transplantation - do they matter?
  37. Posttransplant Allosensitization in Low Immunological Risk Kidney and Kidney-Pancreas Graft Recipients
  38. Handgrip Strength and Associated Factors in Hospitalized Patients
  39. Hand length as an alternative measurement of height
  40. Kidney Transplantation in Type 2 Diabetic Patients: A Matched Survival Analysis
  41. Cardiovascular Risk Factors and Events in Pancreas-Kidney Transplants
  42. Noncutaneous Neoplasms After Kidney Transplantation: Analysis at Single Center
  43. Pregnancy After Kidney Transplantation: Graft, Mother, and Newborn Complications
  44. A Comparison Between Serum Creatinine and Cystatin C-Based Equations for Estimation of Graft Function
  45. Advantages of Kidney Transplant Precocity in Graft Long-Term Survival
  46. Hyperuricemia in Adult Renal Allograft Recipients: Prevalence and Predictors
  47. Over Ten-Year Kidney Graft Survival Determinants
  48. First-Year Renal Function Predicts Long-Term Renal Allograft Loss
  49. Impact of Pediatric Kidney Transplantation on Long-Term Professional and Social Outcomes
  50. Steroid Withdrawal in Simultaneous Pancreas-Kidney Transplantation: A 7-Year Report
  51. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M
  52. Impact Assessment in Living Kidney Donation: Psychosocial Aspects in the Donor
  53. Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M
  54. Low Erythropoietin Production in Familial Amyloidosis TTR V30M Is Not Related with Renal Congophilic Amyloid Deposition
  55. The Influence of HLA Mismatches and Immunosuppression on Kidney Graft Survival: An Analysis of More Than 1300 Patients
  56. Peritoneal Membrane Evaluation in Routine Clinical Practice
  57. Liver transplantation and anemia in familial amyloidosis ATTR V30M
  58. Impact of Hepatitis C Virus on Renal Transplantation: Association With Poor Survival
  59. Renal Transplantation in Patients Over 60 Years of Age: A Single-Center Experience
  60. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation
  61. Immunosuppression With Antithymocyte Globulin in Renal Transplantation: Better Long-Term Graft Survival
  62. Impact of Homocysteinemia on Long-Term Renal Transplant Survival
  63. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry
  64. Kidney and anemia in familial amyloidosis type I
  65. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors
  66. Kinetic modeling studies of ethylene polymerization reactions using supported chromium catalysts
  67. Homocysteine levels in pediatric renal transplant recipients
  68. Lipoprotein(A) in renal transplant recipients
  69. Hyperhomocysteinemia in renal transplantation: preliminary results
  70. Therapy of post-renal transplantation hyperlipidaemia: comparative study with simvastatin and fish oil